Cargando…

The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection globally. There are vaccine candidates in development, but a systematic review on immunogenicity and safety of vaccine is lacking. METHODS: This systematic review of RSV vaccine clinical trials was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Jing, Britton, Philip N., King, Catherine L., Booy, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Formal Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189192/ https://www.ncbi.nlm.nih.gov/pubmed/33764693 http://dx.doi.org/10.1111/irv.12850

Ejemplares similares

Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: A systematic review and meta‐analysis
por: Kenmoe, Sebastien, et al.
Publicado: (2018)

Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
por: Khalaj‐Hedayati, Atin, et al.
Publicado: (2019)

Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis
por: Taniguchi, Kiyosu, et al.
Publicado: (2020)

Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication
por: Hollingsworth, Rosalind, et al.
Publicado: (2020)

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta‐regression analysis
por: Panatto, Donatella, et al.
Publicado: (2018)

Systematic literature review of the signs and symptoms of respiratory syncytial virus
por: Colosia, Ann, et al.
Publicado: (2023)

Research with variola virus after smallpox eradication: Development of a mouse model for variola virus infection
por: Moss, Bernard, et al.
Publicado: (2021)

Diagnostic performance of COVID‐19 serological assays during early infection: A systematic review and meta‐analysis of 11 516 samples
por: Zhang, John J. Y., et al.
Publicado: (2021)

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis
por: Yin, J. Kevin, et al.
Publicado: (2011)

65 years of influenza surveillance by a World Health Organization‐coordinated global network
por: Ziegler, Thedi, et al.
Publicado: (2018)

The viewpoint by White and colleagues critiquing the evaluation of the safety and efficacy of mass chemotherapy for Taenia solium taeniasis is unsubstantiated
por: Haby, Michelle M., et al.
Publicado: (2020)

Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
por: Boccalini, Sara, et al.
Publicado: (2023)

Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022)
por: Riccò, Matteo, et al.
Publicado: (2023)

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates
por: Isaacs, Ariel, et al.
Publicado: (2021)

A comment on: A non-randomized clinical trial to determine the safety and efficacy of a novel sperm sex selection technique
por: Pennings, Guido
Publicado: (2023)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
por: Fries, Louis, et al.
Publicado: (2017)

Comment on "Hotair Is Dispensable for Mouse Development"
por: Li, Lingjie, et al.
Publicado: (2016)

Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients
por: Hayward, Andrew C.
Publicado: (2017)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
por: Peterson, James T, et al.
Publicado: (2021)

Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis
por: Liu, Bei, et al.
Publicado: (2022)

Burden of respiratory syncytial virus in adults in the United Kingdom: A systematic literature review and gap analysis
por: Wilkinson, Tom, et al.
Publicado: (2023)

Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
por: Diamond, David M., et al.
Publicado: (2019)

Language Did Not Spring Forth 100,000 Years Ago
por: Lieberman, Philip
Publicado: (2015)

Is praziquantel preventive chemotherapy associated with visual disorders in Eritrea? A comment on the case series reported by Debesai and Russom
por: Montresor, Antonio, et al.
Publicado: (2020)

Comment on “Large Bottleneck Size in Cauliflower Mosaic Virus Populations during Host Plant Colonization” by Monsion et al. (2008)
por: Thébaud, Gaël, et al.
Publicado: (2016)

Reanalysis shows there is not an extreme decline effect in fish ocean acidification studies
por: Munday, Philip L.
Publicado: (2022)

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review
por: Lv, Meng, et al.
Publicado: (2021)

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
por: Scaggs Huang, Felicia, et al.
Publicado: (2020)

Formal Comment on “Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques” by Bochart et al. (2021)
por: Bohm, Rudolf P., et al.
Publicado: (2022)

Immunogenicity and Protective Efficacy of a Dual Subunit Vaccine Against Respiratory Syncytial Virus and Influenza Virus
por: Park, Min-Hee, et al.
Publicado: (2012)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis
por: Maggi, Stefania, et al.
Publicado: (2022)

Clinical manifestations of respiratory syncytial virus infection and the risk of wheezing and recurrent wheezing illness: a systematic review and meta-analysis
por: Jiang, Ming-Yue, et al.
Publicado: (2023)

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
por: Falsey, Ann R, et al.
Publicado: (2021)

Biodiversity assessments: Origin matters
por: Pauchard, Aníbal, et al.
Publicado: (2018)

Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus
por: Stab, Viktoria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mbaotvfi2jik1dd3hoj6i89p76